Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients. (Record no. 5538)

MARC details
000 -LEADER
fixed length control field 03044nam a22003617a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201006s20202020 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2210-2612
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ijscr.2020.09.017 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S2210-2612(20)30689-1 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 32979826
245 ## - TITLE STATEMENT
Title Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients.
251 ## - Source
Source International Journal of Surgery Case Reports. 75:279-285, 2020 Sep 10.
252 ## - Abbreviated Source
Abbreviated source Int J Surg Case Rep. 75:279-285, 2020 Sep 10.
253 ## - Journal Name
Journal name International journal of surgery case reports
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2020
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2021
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2020-10-06
520 ## - SUMMARY, ETC.
Abstract CONCLUSION: This perioperative FOLFOX treatment was completed in 2 patients and the clinical effectiveness as a result of this in-depth case reports was presented. Formal phase II studies, as a result of these pharmacokinetic and clinical investigations, have been initiated. Copyright (c) 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
520 ## - SUMMARY, ETC.
Abstract DISCUSSION: The compatibility of 5-fluorouracil and oxaliplatin was documented showing no degradation of either drug when they were mixed in-vitro over 24 h. The pharmacokinetic analysis of hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin showed cytotoxic concentrations for 120 min. In order to maximize oxaliplatin's effect, both intravenous bolus and continuous infusion 5-fluorouracil was combined with early postoperative intraperitoneal chemotherapy (EPIC). In total, 200 mg/m2 of oxaliplatin was combined with a minimum of 1600 mg of 5-fluorouracil over the 24 -h treatment plan.
520 ## - SUMMARY, ETC.
Abstract INTRODUCTION: Colorectal cancer can disseminate malignant cells to the peritoneal surfaces which over time progress to peritoneal metastases. Management of this type of metastatic disease has been approached using a combined treatment that consists of cytoreductive surgery and perioperative chemotherapy. To optimize these treatments a more effective chemotherapy that is used as planned part of the surgical procedure is required.
520 ## - SUMMARY, ETC.
Abstract PRESENTATION OF CASES: Pharmacologic studies to initiate a new perioperative chemotherapy treatment were modeled after the successful systemic treatments of metastatic colorectal cancer referred to as FOLFOX. A management plan that included all of the essential features of successful systemic chemotherapy was formulated. Pharmacokinetic studies of 5-fluorouracil given both intravenously and intraperitoneally and oxaliplatin given intraperitoneally were investigated.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution Washington Cancer Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Case Reports
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Stuart, O Anthony
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Sugarbaker, Paul H
790 ## - Authors
All authors Stuart OA, Sugarbaker PH
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1016/j.ijscr.2020.09.017">https://dx.doi.org/10.1016/j.ijscr.2020.09.017</a>
Public note https://dx.doi.org/10.1016/j.ijscr.2020.09.017
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 10/06/2020   32979826 32979826 10/06/2020 10/06/2020 Journal Article

Powered by Koha